Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Keene

Showing results (31-40 of 353) with videos related to

Pageof 36
Sort By:
Experimental and Molecular Pathology|May 8, 2016
Mutational status of IDH1 in uveal melanomaPatrick J Cimino, Yungtai Kung, Joshua I Warrick, et al.
Annual Review of Pathology|January 26, 2021
Genetic Insights into Alzheimer's DiseaseCaitlin S Latimer, Katherine L Lucot, C Dirk Keene, et al.
Biological Psychiatry|August 8, 2021
Traumatic Brain Injury and Risk of Neurodegenerative DisorderBenjamin L Brett, Raquel C Gardner, Jonathan Godbout, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 27, 2024
Suppression of eEF2 phosphorylation alleviates synaptic failure and cognitive deficits in mouse models of Down syndromeXin Wang, Qian Yang, Xueyan Zhou, et al.
Neurosurgery|May 25, 2010
Parahippocampal corpora amylacea: case reportTaylor J Abel, Adam O Hebb, C Dirk Keene, et al.
Experimental and Molecular Pathology|February 6, 2017
Immunohistochemical profiling including beta-catenin in conjunctival melanocytic lesionsHarsha S Reddy, C Dirk Keene, Shu H Chang, et al.
Current Medicinal Chemistry|August 12, 2008
Therapeutic targets in prostaglandin E2 signaling for neurologic diseaseP J Cimino, C Dirk Keene, Richard M Breyer, et al.
The American Journal of Pathology|December 3, 2014
Prostaglandin E2 receptor subtype 2 regulation of scavenger receptor CD36 modulates microglial Aβ42 phagocytosisXianwu Li, Erica Melief, Nadia Postupna, et al.
Magnetic Resonance in Medicine|August 31, 2004
Highly resolved in vivo 1H NMR spectroscopy of the mouse brain at 9.4 TIvan Tkác, Pierre-Gilles Henry, Peter Andersen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 14, 2024
Lewy body pathology modifies risk factors for cerebral amyloid angiopathy when comorbid with Alzheimer's disease pathologyJagan A Pillai, James Bena, Babak Tousi, et al.
Pageof 36

Showing results (31-40 of 353) with videos related to

Sort By:
Pageof 36
Experimental and Molecular Pathology|May 8, 2016
Mutational status of IDH1 in uveal melanomaPatrick J Cimino, Yungtai Kung, Joshua I Warrick, et al.
Annual Review of Pathology|January 26, 2021
Genetic Insights into Alzheimer's DiseaseCaitlin S Latimer, Katherine L Lucot, C Dirk Keene, et al.
Biological Psychiatry|August 8, 2021
Traumatic Brain Injury and Risk of Neurodegenerative DisorderBenjamin L Brett, Raquel C Gardner, Jonathan Godbout, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 27, 2024
Suppression of eEF2 phosphorylation alleviates synaptic failure and cognitive deficits in mouse models of Down syndromeXin Wang, Qian Yang, Xueyan Zhou, et al.
Neurosurgery|May 25, 2010
Parahippocampal corpora amylacea: case reportTaylor J Abel, Adam O Hebb, C Dirk Keene, et al.
Experimental and Molecular Pathology|February 6, 2017
Immunohistochemical profiling including beta-catenin in conjunctival melanocytic lesionsHarsha S Reddy, C Dirk Keene, Shu H Chang, et al.
Current Medicinal Chemistry|August 12, 2008
Therapeutic targets in prostaglandin E2 signaling for neurologic diseaseP J Cimino, C Dirk Keene, Richard M Breyer, et al.
The American Journal of Pathology|December 3, 2014
Prostaglandin E2 receptor subtype 2 regulation of scavenger receptor CD36 modulates microglial Aβ42 phagocytosisXianwu Li, Erica Melief, Nadia Postupna, et al.
Magnetic Resonance in Medicine|August 31, 2004
Highly resolved in vivo 1H NMR spectroscopy of the mouse brain at 9.4 TIvan Tkác, Pierre-Gilles Henry, Peter Andersen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 14, 2024
Lewy body pathology modifies risk factors for cerebral amyloid angiopathy when comorbid with Alzheimer's disease pathologyJagan A Pillai, James Bena, Babak Tousi, et al.
Pageof 36